Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Hodgkin Lymphoma Transplant, Relapsed Disease

Brian Bhatt

MD

🏢University of Pennsylvania🌐USA

Associate Professor of Hematologic Oncology

29
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Brian Bhatt specializes in transplantation strategies for relapsed and refractory Hodgkin lymphoma. His research evaluated salvage chemotherapy regimens including ICE, DHAP, and GDP to optimize response rates before autologous stem cell transplantation. He has studied post-autologous transplant maintenance with brentuximab vedotin based on AETHERA trial findings. His translational work also examines allogeneic transplantation for multiply relapsed Hodgkin lymphoma and the role of checkpoint inhibitor bridging to transplant.

Share:

🧪Research Fields 研究领域

auto-SCT Hodgkin relapse
allogeneic Hodgkin refractory
salvage chemotherapy Hodgkin
GVT effect Hodgkin
post-transplant brentuximab maintenance

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Brian Bhatt 的研究动态

Follow Brian Bhatt's research updates

留下邮箱,当我们发布与 Brian Bhatt(University of Pennsylvania)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment